75 results
Page 2 of 4
8-K
EX-99.1
cd05a4i4 dwfkphrj
5 Apr 22
VBI Vaccines Announces New Data and Progress of VBI-2900, VBI’s eVLP Coronavirus Program
8:00am
8-K
EX-99.1
3m5gdumg7 q0
7 Mar 22
VBI Vaccines Reports Fourth Quarter and Full Year Financial Results for 2021, Provides Corporate Update and Outlook for 2022
8:00am
8-K
EX-99.1
40jkfec 5ccv4t1rqxbm
8 Nov 21
VBI Vaccines Announces Third Quarter 2021 Financial Results and Provides
8:00am
8-K
EX-99.1
lx65krp9 6ff4wv0u8z
2 Aug 21
VBI Vaccines Announces Second Quarter 2021 Financial Results and Provides
8:00am
8-K
EX-99.1
trgy5wv2pu4h72r7
10 May 21
VBI Vaccines Announces First Quarter 2021 Financial Results and Provides Corporate Update
8:00am
8-K
EX-99.2
8krkkjg
10 Mar 21
VBI Vaccines Announces Initiation of Enrollment in Adaptive Phase 1/2 Study of Prophylactic COVID-19 Vaccine Candidate, VBI-2902
7:38am
8-K
EX-99.1
fqgisw
2 Mar 21
VBI Vaccines Reports Fourth Quarter and Full Year Financial Results for 2020, Provides Corporate Update and Outlook for 2021
8:00am
8-K
EX-99.2
8aa8 nswbyboy844v
19 Nov 20
Regulation FD Disclosure
8:00am
8-K
EX-99.1
4yg0 va1glji6aogam
2 Nov 20
VBI Vaccines Announces Third Quarter 2020 Financial Results and Provides Corporate Update
11:31am